| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 ATAD5 POLA1 ZGRF1 CHD1 CHD7 ERVK-7 BPTF ERVK-8 ERCC6L2 | 8.58e-07 | 262 | 101 | 10 | GO:0140097 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.15e-06 | 37 | 101 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.32e-06 | 38 | 101 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | endopeptidase activity | PCSK1 ERVK-6 ADAM18 CTRB2 ERVK-7 ERVK-9 ADGB ERVK-8 PLG ERVK-24 CTRB1 MMP14 | 1.80e-06 | 430 | 101 | 12 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.01e-05 | 11 | 101 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 3.99e-05 | 38 | 101 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 4.39e-05 | 14 | 101 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 4.55e-05 | 127 | 101 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | UBA5 DNAH3 MYO6 ATAD5 ZGRF1 CHD1 CHD7 BPTF ERCC6L2 MACF1 KIF4B DNAH6 | 6.31e-05 | 614 | 101 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 ATAD5 POLA1 ZGRF1 CHD1 CHD7 ERVK-7 BPTF RNASE7 ERVK-8 XRN1 ERCC6L2 | 1.01e-04 | 645 | 101 | 12 | GO:0140640 |
| GeneOntologyMolecularFunction | peptidase activity | PCSK1 ERVK-6 ADAM18 CTRB2 ERVK-7 ERVK-9 ADGB ERVK-8 PLG ERVK-24 CTRB1 MMP14 | 1.15e-04 | 654 | 101 | 12 | GO:0008233 |
| GeneOntologyMolecularFunction | zinc ion binding | UBA5 ERVK-6 HIVEP1 POLA1 ZGRF1 DNAJC21 ERVK-7 ERVK-9 ERVK-8 CIZ1 ZNF638 ERVK-24 MMP14 ADAT2 | 1.55e-04 | 891 | 101 | 14 | GO:0008270 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.56e-04 | 21 | 101 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 6.39e-04 | 136 | 101 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 8.34e-04 | 83 | 101 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 8.61e-04 | 37 | 101 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 8.61e-04 | 37 | 101 | 3 | GO:0140658 | |
| GeneOntologyMolecularFunction | transition metal ion binding | UBA5 ERVK-6 HIVEP1 POLA1 ZGRF1 DNAJC21 ERVK-7 ERVK-9 HPD ERVK-8 CIZ1 ZNF638 ERVK-24 MMP14 ADAT2 | 9.16e-04 | 1189 | 101 | 15 | GO:0046914 |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.05e-03 | 152 | 101 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.63e-03 | 46 | 101 | 3 | GO:0016893 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 3.13e-05 | 178 | 103 | 7 | GO:0006261 | |
| GeneOntologyBiologicalProcess | DNA integration | 3.34e-05 | 13 | 103 | 3 | GO:0015074 | |
| HumanPheno | Abnormal response to endocrine stimulation test | 6.52e-06 | 153 | 35 | 8 | HP:0031073 | |
| HumanPheno | Abnormal endocrine physiology | 7.53e-06 | 156 | 35 | 8 | HP:0031072 | |
| HumanPheno | Decreased response to growth hormone stimulation test | 2.98e-05 | 136 | 35 | 7 | HP:0000824 | |
| HumanPheno | Abnormal growth hormone level | 6.64e-05 | 154 | 35 | 7 | HP:0032367 | |
| MousePheno | enlarged stomach | 1.62e-06 | 33 | 86 | 5 | MP:0003883 | |
| Domain | Znf_C2H2_jaz | 1.89e-04 | 22 | 96 | 3 | IPR022755 | |
| Domain | zf-C2H2_jaz | 1.89e-04 | 22 | 96 | 3 | PF12171 | |
| Domain | - | 3.87e-04 | 6 | 96 | 2 | 3.90.1290.10 | |
| Domain | ZnF_U1 | 4.36e-04 | 29 | 96 | 3 | SM00451 | |
| Domain | Znf_U1 | 4.36e-04 | 29 | 96 | 3 | IPR003604 | |
| Domain | Plectin_repeat | 5.40e-04 | 7 | 96 | 2 | IPR001101 | |
| Domain | Plectin | 5.40e-04 | 7 | 96 | 2 | PF00681 | |
| Domain | PLEC | 5.40e-04 | 7 | 96 | 2 | SM00250 | |
| Domain | SNF2_N | 5.86e-04 | 32 | 96 | 3 | IPR000330 | |
| Domain | SNF2_N | 5.86e-04 | 32 | 96 | 3 | PF00176 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 7.64e-04 | 35 | 96 | 3 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 9.74e-04 | 38 | 96 | 3 | PS00690 | |
| Domain | Znf_C2H2_matrin | 1.67e-03 | 12 | 96 | 2 | IPR000690 | |
| Domain | TTL | 1.97e-03 | 13 | 96 | 2 | PS51221 | |
| Domain | TTL/TTLL_fam | 1.97e-03 | 13 | 96 | 2 | IPR004344 | |
| Domain | TTL | 1.97e-03 | 13 | 96 | 2 | PF03133 | |
| Domain | SANT | 2.17e-03 | 50 | 96 | 3 | SM00717 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.29e-03 | 14 | 96 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 2.29e-03 | 14 | 96 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 2.29e-03 | 14 | 96 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.29e-03 | 14 | 96 | 2 | PF08393 | |
| Domain | MT | 2.29e-03 | 14 | 96 | 2 | PF12777 | |
| Domain | AAA_8 | 2.29e-03 | 14 | 96 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 2.29e-03 | 14 | 96 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.29e-03 | 14 | 96 | 2 | PF07728 | |
| Domain | SANT/Myb | 2.42e-03 | 52 | 96 | 3 | IPR001005 | |
| Domain | DHC_fam | 2.63e-03 | 15 | 96 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.63e-03 | 15 | 96 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.63e-03 | 15 | 96 | 2 | PF03028 | |
| Domain | ATP_grasp_subdomain_1 | 3.79e-03 | 18 | 96 | 2 | IPR013815 | |
| Domain | ZF_MATRIN | 3.79e-03 | 18 | 96 | 2 | PS50171 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 1.93e-05 | 33 | 69 | 4 | M26976 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 3.42e-05 | 38 | 69 | 4 | MM14611 | |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 1.27e-11 | 8 | 105 | 5 | 12634303 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.07e-07 | 4 | 105 | 3 | 10469592 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | HIVEP1 DSP ATAD5 CHD1 CHD7 THOC2 JMJD1C BPTF PPP1R10 TOX4 CIZ1 ZNF638 TAF1L TADA3 KNL1 | 1.88e-07 | 954 | 105 | 15 | 36373674 |
| Pubmed | 1.48e-06 | 8 | 105 | 3 | 31537781 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | VRK2 DSP ATAD5 CHD7 THOC2 JMJD1C BPTF PPP1R10 KMT2D TOX4 YAF2 CIZ1 ZNF638 TAF1L TADA3 TBL2 | 1.71e-06 | 1294 | 105 | 16 | 30804502 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | MIS18BP1 HIVEP1 ATAD5 POLA1 CHD1 CHD7 JMJD1C BPTF PPP1R10 CIZ1 TIMELESS | 2.41e-06 | 608 | 105 | 11 | 36089195 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.45e-06 | 283 | 105 | 8 | 30585729 | |
| Pubmed | 5.22e-06 | 418 | 105 | 9 | 34709266 | ||
| Pubmed | 5.77e-06 | 12 | 105 | 3 | 14557543 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 28951524 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 28754779 | ||
| Pubmed | Molecular cloning and nucleotide sequence of human pancreatic prechymotrypsinogen cDNA. | 9.03e-06 | 2 | 105 | 2 | 2917002 | |
| Pubmed | Genomic cloning and partial characterization of human chymotrypsinogen gene. | 9.03e-06 | 2 | 105 | 2 | 8186414 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 28475860 | ||
| Pubmed | Chymotrypsin Reduces the Severity of Secretagogue-Induced Pancreatitis in Mice. | 9.03e-06 | 2 | 105 | 2 | 30076839 | |
| Pubmed | Sequencing of the complex CTRB1-CTRB2 locus in chronic pancreatitis. | 9.03e-06 | 2 | 105 | 2 | 33036922 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 2565717 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 19293638 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 9.61e-06 | 341 | 105 | 8 | 32971831 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.01e-05 | 94 | 105 | 5 | 21542922 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | FNDC3B MYO6 DOCK11 ATAD5 POLA1 DNAJC21 PPP1R10 MYOF XRN1 MACF1 TADA3 | 1.25e-05 | 724 | 105 | 11 | 36232890 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 1.51e-05 | 363 | 105 | 8 | 14691545 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MYO6 DSP ATAD5 CHD1 THOC2 PPP1R10 TOX4 CIZ1 XRN1 ZNF638 MACF1 KNL1 | 2.60e-05 | 934 | 105 | 12 | 33916271 |
| Pubmed | 2.60e-05 | 191 | 105 | 6 | 31177093 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 28007623 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 1016231 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 9971820 | ||
| Pubmed | In search of key genes associated with endometriosis using bioinformatics approach. | 2.70e-05 | 3 | 105 | 2 | 26366788 | |
| Pubmed | Control of SARS-CoV-2 infection by MT1-MMP-mediated shedding of ACE2. | 2.70e-05 | 3 | 105 | 2 | 36564389 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 34643096 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 32678161 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 29292760 | ||
| Pubmed | Secretagogue-induced pancreatitis in mice devoid of chymotrypsin. | 2.70e-05 | 3 | 105 | 2 | 38981616 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 1008801 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 32372285 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 3.66e-05 | 203 | 105 | 6 | 22083510 | |
| Pubmed | 3.95e-05 | 22 | 105 | 3 | 33304758 | ||
| Pubmed | 4.47e-05 | 549 | 105 | 9 | 38280479 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 6264318 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 12151598 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 12935900 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 11175280 | ||
| Pubmed | A functional overlap of plasminogen and MMPs regulates vascularization during placental development. | 5.40e-05 | 4 | 105 | 2 | 12900459 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 14651966 | ||
| Pubmed | 8.04e-05 | 234 | 105 | 6 | 36243803 | ||
| Pubmed | 8.04e-05 | 340 | 105 | 7 | 24332808 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 8.97e-05 | 5 | 105 | 2 | 12629516 | |
| Pubmed | Chromosomal assignments of genes for trypsin, chymotrypsin B, and elastase in mouse. | 8.97e-05 | 5 | 105 | 2 | 6589791 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 8.97e-05 | 5 | 105 | 2 | 11401426 | |
| Pubmed | Genetic study of pancreatic proteinase and alpha-amylase in mice (Mus musculus). | 8.97e-05 | 5 | 105 | 2 | 4461036 | |
| Pubmed | Genetic and biochemical characterization of a new chymotrypsin isozyme of the house mouse, CTRA-1. | 8.97e-05 | 5 | 105 | 2 | 1820020 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 16147977 | ||
| Pubmed | 9.58e-05 | 472 | 105 | 8 | 38943005 | ||
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 1.13e-04 | 31 | 105 | 3 | 20516061 | |
| Pubmed | 1.17e-04 | 486 | 105 | 8 | 20936779 | ||
| Pubmed | 1.18e-04 | 157 | 105 | 5 | 30186101 | ||
| Pubmed | 1.20e-04 | 83 | 105 | 4 | 28794006 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 23814066 | ||
| Pubmed | CHARGE and Kabuki syndromes: a phenotypic and molecular link. | 1.34e-04 | 6 | 105 | 2 | 24705355 | |
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 15063128 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 21641389 | ||
| Pubmed | A quantitative telomeric chromatin isolation protocol identifies different telomeric states. | 1.49e-04 | 34 | 105 | 3 | 24270157 | |
| Pubmed | 1.52e-04 | 263 | 105 | 6 | 34702444 | ||
| Pubmed | FNDC3B VRK2 ATAD5 DNAJC21 CHD1 CHD7 PPP1R10 MYOF CIZ1 XRN1 MACF1 TAF1L TADA3 TBL2 | 1.66e-04 | 1497 | 105 | 14 | 31527615 | |
| Pubmed | 1.66e-04 | 653 | 105 | 9 | 22586326 | ||
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 15545316 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.47e-04 | 184 | 105 | 5 | 32908313 | |
| Pubmed | 2.50e-04 | 8 | 105 | 2 | 36577382 | ||
| Pubmed | 2.50e-04 | 8 | 105 | 2 | 18286207 | ||
| Pubmed | Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation. | 2.50e-04 | 8 | 105 | 2 | 21447625 | |
| Pubmed | A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. | 3.21e-04 | 9 | 105 | 2 | 16728976 | |
| Pubmed | Novel gene function revealed by mouse mutagenesis screens for models of age-related disease. | 3.24e-04 | 44 | 105 | 3 | 27534441 | |
| Pubmed | 3.38e-04 | 197 | 105 | 5 | 23686814 | ||
| Pubmed | HIVEP1 MYO6 ATAD5 CHD7 JMJD1C BPTF KMT2D YAF2 SPZ1 XRN1 ZNF638 TAF1L TADA3 | 3.76e-04 | 1429 | 105 | 13 | 35140242 | |
| Pubmed | 3.88e-04 | 733 | 105 | 9 | 34672954 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 3.95e-04 | 582 | 105 | 8 | 20467437 | |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 4.00e-04 | 315 | 105 | 6 | 26777405 | |
| Pubmed | 4.00e-04 | 10 | 105 | 2 | 21945076 | ||
| Pubmed | 4.37e-04 | 591 | 105 | 8 | 15231748 | ||
| Pubmed | 4.77e-04 | 119 | 105 | 4 | 23508102 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 4.86e-04 | 457 | 105 | 7 | 32344865 | |
| Pubmed | 4.88e-04 | 11 | 105 | 2 | 21038445 | ||
| Pubmed | 4.88e-04 | 11 | 105 | 2 | 20363151 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TTLL3 MYO6 SLITRK3 JMJD1C ITFG1 SHISA9 BPTF TBC1D1 ZNF638 MACF1 AADAT ADAT2 DOP1A | 5.53e-04 | 1489 | 105 | 13 | 28611215 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 5.74e-04 | 774 | 105 | 9 | 15302935 | |
| Pubmed | 5.93e-04 | 54 | 105 | 3 | 22266860 | ||
| Pubmed | A targeted multienzyme mechanism for selective microtubule polyglutamylation. | 6.89e-04 | 13 | 105 | 2 | 17499049 | |
| Pubmed | 6.89e-04 | 13 | 105 | 2 | 11468771 | ||
| Pubmed | 7.20e-04 | 638 | 105 | 8 | 31182584 | ||
| Pubmed | 7.72e-04 | 645 | 105 | 8 | 25281560 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 7.96e-04 | 497 | 105 | 7 | 36774506 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FNDC3B MIS18BP1 MYO6 DSP POLA1 CHD1 CHD7 MELK XRN1 ZNF638 MACF1 MMP14 | 7.96e-04 | 1353 | 105 | 12 | 29467282 |
| Pubmed | Th2 and eosinophil responses suppress inflammatory arthritis. | 8.02e-04 | 14 | 105 | 2 | 27273006 | |
| Pubmed | ZW10 links mitotic checkpoint signaling to the structural kinetochore. | 8.02e-04 | 14 | 105 | 2 | 15824131 | |
| Pubmed | Mouse chromosomal location of four Na/H exchanger isoform genes. | 8.02e-04 | 14 | 105 | 2 | 8824815 | |
| Pubmed | 8.02e-04 | 14 | 105 | 2 | 9373155 | ||
| Pubmed | 8.59e-04 | 242 | 105 | 5 | 34011540 | ||
| Pubmed | CUL2LRR1 , TRAIP and p97 control CMG helicase disassembly in the mammalian cell cycle. | 9.24e-04 | 15 | 105 | 2 | 33590678 | |
| Pubmed | 1.01e-03 | 251 | 105 | 5 | 31076518 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | FNDC3B VRK2 MIS18BP1 DSP POR CHD1 THOC2 JMJD1C ITFG1 PPP1R10 TIMELESS | 1.04e-03 | 1203 | 105 | 11 | 29180619 |
| Interaction | HPD interactions | 1.19e-06 | 17 | 98 | 4 | int:HPD | |
| Interaction | ANKRD20A4P interactions | 2.21e-06 | 6 | 98 | 3 | int:ANKRD20A4P | |
| Interaction | ANKRD20A2P interactions | 3.85e-06 | 7 | 98 | 3 | int:ANKRD20A2P | |
| Interaction | PHF21A interactions | 6.65e-06 | 343 | 98 | 10 | int:PHF21A | |
| Interaction | ANKRD20A1 interactions | 1.79e-05 | 11 | 98 | 3 | int:ANKRD20A1 | |
| Interaction | SMC5 interactions | HIVEP1 DSP ATAD5 CHD1 CHD7 THOC2 JMJD1C BPTF PPP1R10 TOX4 CIZ1 ZNF638 TIMELESS TAF1L TADA3 KNL1 | 2.46e-05 | 1000 | 98 | 16 | int:SMC5 |
| Interaction | RCOR1 interactions | HIVEP1 DSP ZGRF1 CHD7 JMJD1C ITFG1 ESCO2 KMT2D TOX4 XRN1 KNL1 | 2.82e-05 | 494 | 98 | 11 | int:RCOR1 |
| Interaction | NUP43 interactions | MIS18BP1 HIVEP1 DSP POLA1 CHD1 JMJD1C BPTF KMT2D CIZ1 TIMELESS TADA3 KNL1 | 5.08e-05 | 625 | 98 | 12 | int:NUP43 |
| Interaction | H2BC9 interactions | HIVEP1 TRAF3IP1 MYO6 DSP DNAJC21 SLITRK3 NEB BPTF KIF4B DNAH6 | 6.28e-05 | 446 | 98 | 10 | int:H2BC9 |
| Interaction | CTRB2 interactions | 7.00e-05 | 3 | 98 | 2 | int:CTRB2 | |
| Interaction | TERF2IP interactions | HIVEP1 ATAD5 POLA1 CHD1 CHD7 THOC2 BPTF PPP1R10 CIZ1 ZNF638 KNL1 | 7.67e-05 | 552 | 98 | 11 | int:TERF2IP |
| Cytoband | 5q15-q21 | 5.18e-06 | 2 | 105 | 2 | 5q15-q21 | |
| GeneFamily | EF-hand domain containing|Plakins | 3.62e-04 | 8 | 66 | 2 | 939 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 9.55e-04 | 53 | 66 | 3 | 532 | |
| GeneFamily | Tubulin tyrosine ligase family | 1.16e-03 | 14 | 66 | 2 | 779 | |
| GeneFamily | Dyneins, axonemal | 1.72e-03 | 17 | 66 | 2 | 536 | |
| GeneFamily | Ankyrin repeat domain containing | 1.90e-03 | 242 | 66 | 5 | 403 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.32e-03 | 181 | 66 | 4 | 694 | |
| Coexpression | DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS | DNAH3 TRAF3IP1 ANKRD18B ADGB TMEM232 NEK5 CFAP221 STK33 DNAH6 | 3.03e-06 | 317 | 98 | 9 | M40298 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | PCSK1 ZWILCH MIS18BP1 ATAD5 POLA1 ZGRF1 CHD7 MELK PARP6 KIF4B KNL1 MYBL1 | 8.95e-06 | 680 | 98 | 12 | MM456 |
| Coexpression | GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP | 1.04e-05 | 200 | 98 | 7 | M3577 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | ZWILCH MIS18BP1 ATAD5 POLA1 MELK ESCO2 KIF4B TIMELESS TBL2 KNL1 MYBL1 | 1.46e-05 | 597 | 98 | 11 | MM1309 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 2.03e-05 | 402 | 98 | 9 | MM454 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | 2.87e-05 | 322 | 98 | 8 | M39060 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP | 2.93e-05 | 323 | 98 | 8 | M2156 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | 3.56e-05 | 432 | 98 | 9 | MM419 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | 5.68e-05 | 459 | 98 | 9 | M39136 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | ZWILCH MIS18BP1 ATAD5 POLA1 MELK ESCO2 TIMELESS TBL2 KNL1 MYBL1 | 6.19e-05 | 578 | 98 | 10 | M2368 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 7.43e-05 | 187 | 98 | 6 | M2984 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 9.63e-05 | 196 | 98 | 6 | M5381 | |
| Coexpression | GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP | 9.90e-05 | 197 | 98 | 6 | M3136 | |
| Coexpression | GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_UP | 1.02e-04 | 198 | 98 | 6 | M9704 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 1.08e-04 | 200 | 98 | 6 | M3580 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 1.08e-04 | 200 | 98 | 6 | M9135 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGBP | 1.36e-04 | 300 | 98 | 7 | M39059 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | MIS18BP1 MYO6 CHD1 TTLL7 ITFG1 BPTF ZNF638 ZNF700 KNL1 MYBL1 | 1.74e-04 | 656 | 98 | 10 | M18979 |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | FMO5 ZGRF1 ANKRD20A3P ANKRD20A8P ANKRD18B ITFG1 PARP6 TOX4 ANKRD20A4P STK33 XRN1 ANKRD20A1 | 1.83e-04 | 930 | 98 | 12 | MM893 |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | ZWILCH MIS18BP1 ATAD5 POLA1 ZGRF1 SLAMF1 MELK ESCO2 NSG2 TIMELESS KNL1 MYBL1 | 2.71e-07 | 398 | 97 | 12 | GSM399397_500 |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | ZWILCH MIS18BP1 ATAD5 POLA1 ZGRF1 MELK ESCO2 SIGLEC10 TIMELESS MMP14 KNL1 MYBL1 | 3.62e-07 | 409 | 97 | 12 | GSM399452_500 |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | PCSK1 ZWILCH MIS18BP1 ATAD5 POLA1 ZNF683 MELK ESCO2 NSG2 SAMD3 KNL1 | 2.05e-06 | 398 | 97 | 11 | GSM538338_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | ZWILCH MIS18BP1 ATAD5 POLA1 ZGRF1 SLAMF1 MELK ESCO2 SYT11 TIMELESS KNL1 | 2.73e-06 | 410 | 97 | 11 | GSM538387_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 6.28e-06 | 152 | 97 | 7 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_500 | |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | ZWILCH MIS18BP1 ATAD5 POLA1 SLAMF1 MELK ESCO2 SIGLEC10 KNL1 MYBL1 | 9.44e-06 | 380 | 97 | 10 | GSM538207_500 |
| CoexpressionAtlas | alpha beta T cells, NKT.44+NK1.1-.Th, aGC CD1d tet CD3 CD44, Thymus, avg-3 | PCSK1 ZWILCH MIS18BP1 POLA1 ZNF683 MELK ESCO2 NSG2 SAMD3 KNL1 | 1.24e-05 | 392 | 97 | 10 | GSM538335_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#3_top-relative-expression-ranked_500 | 1.39e-05 | 114 | 97 | 6 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k3_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | ZWILCH MIS18BP1 ATAD5 POLA1 CHD7 SLAMF1 MELK ESCO2 SYT11 KNL1 | 1.54e-05 | 402 | 97 | 10 | GSM605898_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.e17.Th, TCRd+ Vg2+ CD24+, Fetal Thymus, avg-3 | ZWILCH MIS18BP1 ATAD5 POLA1 CHD7 SLAMF1 MELK ESCO2 HECTD2 KNL1 | 1.98e-05 | 414 | 97 | 10 | GSM476660_500 |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | ZWILCH MIS18BP1 ATAD5 POLA1 ZGRF1 MELK ESCO2 NSG2 TIMELESS KNL1 | 2.10e-05 | 417 | 97 | 10 | GSM399403_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | ZWILCH MIS18BP1 ATAD5 POLA1 CDKL3 DNAJC21 CHD1 CHD7 NECTIN3 PPP1R10 SYT11 HECTD2 MACF1 GABRA1 KNL1 MYBL1 | 2.33e-05 | 1060 | 97 | 16 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | alpha beta T cells, T.8SP24int.Th, 4- 8+ TCRhi 24int, Thymus, avg-3 | 2.52e-05 | 339 | 97 | 9 | GSM399382_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | ZWILCH RBM44 MIS18BP1 POLA1 ZGRF1 DNAJC21 MELK ESCO2 ERCC6L2 | 4.12e-05 | 361 | 97 | 9 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 |
| CoexpressionAtlas | alpha beta T cells, T.DN4.Th, Lin-/lo CD25- CD44- CD28+, Thymus, avg-3 | 5.64e-05 | 376 | 97 | 9 | GSM791154_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | 6.76e-05 | 385 | 97 | 9 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 | |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | ZWILCH MIS18BP1 ATAD5 POLA1 ZGRF1 DNAJC21 ESCO2 SIGLEC10 KNL1 | 8.23e-05 | 395 | 97 | 9 | GSM538340_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 9.04e-05 | 311 | 97 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | B cells, proB.FrBC.FL, CD19+ IgM- CD43+ CD24+ AA4.1+ CD45R+, Fetal Liver, avg-3 | 9.05e-05 | 400 | 97 | 9 | GSM538358_500 | |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2 | ZWILCH MIS18BP1 ATAD5 POLA1 DNAJC21 MELK ESCO2 SIGLEC10 KNL1 | 9.22e-05 | 401 | 97 | 9 | GSM399450_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 1.21e-04 | 105 | 97 | 5 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | 1.29e-04 | 419 | 97 | 9 | GSM476664_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | 1.36e-04 | 422 | 97 | 9 | GSM476658_500 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | 1.36e-04 | 422 | 97 | 9 | GSM538357_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | ZWILCH MIS18BP1 TRAF3IP1 ATAD5 POLA1 ZGRF1 DNAJC21 CHD1 THOC2 ESCO2 BPTF SYT11 HECTD2 MACF1 KNL1 MYBL1 | 1.74e-04 | 1257 | 97 | 16 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 2.13e-04 | 186 | 97 | 6 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.20e-04 | 266 | 97 | 7 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 2.52e-04 | 192 | 97 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | HIVEP1 TRAF3IP1 ATAD5 ZGRF1 CHD7 THOC2 JMJD1C BPTF MACF1 KNL1 | 2.56e-04 | 564 | 97 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 2.97e-04 | 469 | 97 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | ZWILCH MIS18BP1 TRAF3IP1 ATAD5 POLA1 ZGRF1 DNAJC21 CHD1 CHD7 THOC2 ESCO2 BPTF SYT11 HECTD2 MACF1 KNL1 MYBL1 | 3.05e-04 | 1459 | 97 | 17 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3 | 3.12e-04 | 373 | 97 | 8 | GSM605781_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | ZWILCH RBM44 MIS18BP1 DSP POLA1 ZGRF1 DNAJC21 MELK ESCO2 ERCC6L2 DOP1A MYBL1 | 3.56e-04 | 820 | 97 | 12 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#2_top-relative-expression-ranked_500 | 4.45e-04 | 139 | 97 | 5 | gudmap_kidney_e10.5_UretericTip_HoxB7_k2_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN3-4.Th, Lin-/lo CD25int CD44- CD28+, Thymus, avg-3 | 4.72e-04 | 397 | 97 | 8 | GSM791143_500 | |
| CoexpressionAtlas | B cells, proB.CLP.BM, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Bone marrow, avg-2 | 4.88e-04 | 399 | 97 | 8 | GSM538345_500 | |
| CoexpressionAtlas | Stem Cells, SC.CDP.BM, Sca1- Flt3+ MCSFR+ cKitlo, Bone marrow, avg-3 | 5.04e-04 | 401 | 97 | 8 | GSM791114_500 | |
| CoexpressionAtlas | Stem Cells, SC.MDP.BM, Sca1- Flt3+ MCSFR+ cKithi, Bone marrow, avg-3 | 5.13e-04 | 402 | 97 | 8 | GSM791105_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | 5.47e-04 | 406 | 97 | 8 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ZWILCH TRAF3IP1 ATAD5 POLA1 DNAJC21 CHD1 CHD7 NECTIN3 NSG2 SYT11 HECTD2 KNL1 MYBL1 | 5.55e-04 | 989 | 97 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#3_top-relative-expression-ranked_100 | 6.41e-04 | 37 | 97 | 3 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k3_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_200 | 6.41e-04 | 37 | 97 | 3 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_200 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | ZWILCH MIS18BP1 ATAD5 POLA1 CDKL3 DNAJC21 CHD1 CHD7 NECTIN3 PPP1R10 SYT11 HECTD2 MACF1 GABRA1 KNL1 MYBL1 | 6.44e-04 | 1414 | 97 | 16 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate CD45R- AA4.1+ CD, Fetal Liver, avg-1 | 6.62e-04 | 418 | 97 | 8 | GSM538350_500 | |
| CoexpressionAtlas | B cells, proB.CLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-2 | 6.72e-04 | 419 | 97 | 8 | GSM538348_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN2B.Th, Lin-/lo CD25hi CD44+ cKitint, Thymus, avg-2 | 6.83e-04 | 420 | 97 | 8 | GSM791141_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | 6.93e-04 | 421 | 97 | 8 | gudmap_developingKidney_e15.5_Peripheral blastema_500 | |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | 7.04e-04 | 422 | 97 | 8 | GSM538355_500 | |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | 7.15e-04 | 423 | 97 | 8 | GSM791126_500 | |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 7.74e-04 | 90 | 97 | 4 | GSM399403_100 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-10 | 167 | 100 | 9 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-10 | 169 | 100 | 9 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.26e-10 | 199 | 100 | 9 | 616c04b0605907fb218263f2164c36cb2fa26b87 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.17e-08 | 190 | 100 | 8 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.32e-08 | 193 | 100 | 8 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-08 | 195 | 100 | 8 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.43e-08 | 195 | 100 | 8 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-08 | 195 | 100 | 8 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-08 | 195 | 100 | 8 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.48e-08 | 196 | 100 | 8 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.48e-08 | 196 | 100 | 8 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.67e-08 | 199 | 100 | 8 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.74e-08 | 200 | 100 | 8 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-08 | 200 | 100 | 8 | 43571c9284d4e41402a2d1eefc1efe2ce8476d4a | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.68e-08 | 163 | 100 | 7 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.44e-08 | 165 | 100 | 7 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.84e-08 | 166 | 100 | 7 | a41a20cef053c67da2d435e3e132ce28f1661c03 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-07 | 167 | 100 | 7 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-07 | 169 | 100 | 7 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.11e-07 | 169 | 100 | 7 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-07 | 169 | 100 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-07 | 169 | 100 | 7 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-07 | 172 | 100 | 7 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-07 | 175 | 100 | 7 | ae7e0448ffd11b8908d0f6d99ff737faf5eca4bf | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-07 | 179 | 100 | 7 | 54621d2b3a66e62aa76b7e444118878ed97c1e02 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-07 | 179 | 100 | 7 | 54191c00b29f53b520cd3243b5791daa4a2c72d7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-07 | 179 | 100 | 7 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.71e-07 | 180 | 100 | 7 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-07 | 180 | 100 | 7 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-07 | 182 | 100 | 7 | e78ba2c5cae480c16a596ce7c3bf2d480becacf4 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-07 | 182 | 100 | 7 | 1710eab3037a87609d21838be2d2d29c3bc36651 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.98e-07 | 184 | 100 | 7 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.06e-07 | 185 | 100 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-07 | 185 | 100 | 7 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.13e-07 | 186 | 100 | 7 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.13e-07 | 186 | 100 | 7 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 2.21e-07 | 187 | 100 | 7 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-07 | 187 | 100 | 7 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 2.29e-07 | 188 | 100 | 7 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-07 | 189 | 100 | 7 | b55de812043b670cbde810d7d42f45909b6d66ef | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-07 | 189 | 100 | 7 | 02c6128a9ab5818e0881dcadafdad5f08b9a67cf | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-07 | 189 | 100 | 7 | 164ea92ff6a1aa2ead1c9b8f64f99a9d65437232 | |
| ToppCell | Epithelial-D_(Ciliated)|World / shred on cell class and cell subclass (v4) | 2.38e-07 | 189 | 100 | 7 | 0bf560b595c7a8450a46bc821b742b67965bd9f9 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-07 | 189 | 100 | 7 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-07 | 189 | 100 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.38e-07 | 189 | 100 | 7 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.38e-07 | 189 | 100 | 7 | 4e83e49d1265ffe507fdb72924c77c4d1c73f0bd | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-07 | 190 | 100 | 7 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.55e-07 | 191 | 100 | 7 | 2a8e6d560907e71e9f6e190ca0667da804e25641 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.55e-07 | 191 | 100 | 7 | 46c9d4d10c66c0fae1fa351924091b69ea2f38d4 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-07 | 191 | 100 | 7 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-07 | 191 | 100 | 7 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | Mild_COVID-19-Epithelial-Ciliated|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.55e-07 | 191 | 100 | 7 | 995e76bbf07674d95b8ef09e078cf6410af27a09 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.55e-07 | 191 | 100 | 7 | a37f20172b85566b9039254a89680e37fd503fd5 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Ciliated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.55e-07 | 191 | 100 | 7 | 2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.64e-07 | 192 | 100 | 7 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-07 | 192 | 100 | 7 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.64e-07 | 192 | 100 | 7 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.64e-07 | 192 | 100 | 7 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.64e-07 | 192 | 100 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.64e-07 | 192 | 100 | 7 | 2d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.74e-07 | 193 | 100 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.74e-07 | 193 | 100 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.74e-07 | 193 | 100 | 7 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.84e-07 | 194 | 100 | 7 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.84e-07 | 194 | 100 | 7 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.84e-07 | 194 | 100 | 7 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.84e-07 | 194 | 100 | 7 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 2.84e-07 | 194 | 100 | 7 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.94e-07 | 195 | 100 | 7 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.94e-07 | 195 | 100 | 7 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.94e-07 | 195 | 100 | 7 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.94e-07 | 195 | 100 | 7 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.94e-07 | 195 | 100 | 7 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.94e-07 | 195 | 100 | 7 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.94e-07 | 195 | 100 | 7 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.04e-07 | 196 | 100 | 7 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.04e-07 | 196 | 100 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.04e-07 | 196 | 100 | 7 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.04e-07 | 196 | 100 | 7 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.04e-07 | 196 | 100 | 7 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.04e-07 | 196 | 100 | 7 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.04e-07 | 196 | 100 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.04e-07 | 196 | 100 | 7 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.15e-07 | 197 | 100 | 7 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.15e-07 | 197 | 100 | 7 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.15e-07 | 197 | 100 | 7 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | distal-Hematologic-Proliferating_NK/T-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.15e-07 | 197 | 100 | 7 | 04b10879e48c101d1de449db0bc6b6484090b965 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | 3.26e-07 | 198 | 100 | 7 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.37e-07 | 199 | 100 | 7 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.37e-07 | 199 | 100 | 7 | fba48342066aab41a8bcb20db40a6df0158e1cbe | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-07 | 199 | 100 | 7 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.37e-07 | 199 | 100 | 7 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 200 | 100 | 7 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 200 | 100 | 7 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 200 | 100 | 7 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.48e-07 | 200 | 100 | 7 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 200 | 100 | 7 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.48e-07 | 200 | 100 | 7 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | Biopsy_IPF-Epithelial-Ciliated|Biopsy_IPF / Sample group, Lineage and Cell type | 3.48e-07 | 200 | 100 | 7 | bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8 | |
| Drug | AC1O52A0 | 7.92e-07 | 5 | 99 | 3 | CID006475891 | |
| Drug | L-659,286 | 1.58e-06 | 6 | 99 | 3 | CID000128954 | |
| Drug | Leupeptin acid | 1.58e-06 | 6 | 99 | 3 | CID000189069 | |
| Drug | ATNE | 4.40e-06 | 8 | 99 | 3 | CID000130551 | |
| Drug | Bio-Phe-CH2Cl | 4.40e-06 | 8 | 99 | 3 | CID000083924 | |
| Drug | Bio-Arg-CH2Cl | 4.40e-06 | 8 | 99 | 3 | CID000083923 | |
| Drug | FK-401 | 6.57e-06 | 9 | 99 | 3 | CID000135041 | |
| Drug | tlmE | 6.57e-06 | 9 | 99 | 3 | CID000188322 | |
| Drug | RD4-6205 | 9.36e-06 | 10 | 99 | 3 | CID003002865 | |
| Drug | benzyl sulfonate | 1.28e-05 | 11 | 99 | 3 | CID000007532 | |
| Drug | p-hydroxyphenyllactic acid | 1.78e-05 | 36 | 99 | 4 | CID000009378 | |
| Drug | BOCPheONP | 1.87e-05 | 2 | 99 | 2 | CID000111308 | |
| Drug | MPM-06 | 1.87e-05 | 2 | 99 | 2 | CID000161546 | |
| Drug | NSC-374899 | 1.87e-05 | 2 | 99 | 2 | CID000435726 | |
| Drug | methylbenzenebutanoate | 1.87e-05 | 2 | 99 | 2 | CID000281254 | |
| Drug | Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu | 1.87e-05 | 2 | 99 | 2 | CID004418081 | |
| Drug | c189 | 1.87e-05 | 2 | 99 | 2 | CID000248048 | |
| Drug | dansyl-D-arginine methyl ester | 1.87e-05 | 2 | 99 | 2 | CID000191369 | |
| Drug | methyl 6-phenylhexanoate | 1.87e-05 | 2 | 99 | 2 | CID011820300 | |
| Drug | 5-aminotetrazole | 1.87e-05 | 2 | 99 | 2 | CID000020467 | |
| Drug | 2-bromoisobutyric acid | 1.87e-05 | 2 | 99 | 2 | CID000074924 | |
| Drug | p-toluamidine | 1.87e-05 | 2 | 99 | 2 | CID000122753 | |
| Drug | N-acetyl-alpha-azaphenylalanine phenyl ester | 1.87e-05 | 2 | 99 | 2 | CID000191275 | |
| Drug | isobutyl sulfide | 1.87e-05 | 2 | 99 | 2 | CID000011607 | |
| Drug | phenyl 4-guanidinobenzoate | 2.21e-05 | 13 | 99 | 3 | CID003015798 | |
| Drug | Lga-afc | 2.21e-05 | 13 | 99 | 3 | CID003081120 | |
| Drug | AC1Q5JSU | 2.80e-05 | 14 | 99 | 3 | CID000093061 | |
| Drug | Erp tripeptide | 2.80e-05 | 14 | 99 | 3 | CID000131430 | |
| Drug | De 1 | 5.19e-05 | 17 | 99 | 3 | CID006453604 | |
| Drug | Terbium monoxide | 5.19e-05 | 17 | 99 | 3 | CID000518482 | |
| Drug | N-acetylbenzotriazole | 5.60e-05 | 3 | 99 | 2 | CID000087784 | |
| Drug | photophor | 5.60e-05 | 3 | 99 | 2 | CID000014780 | |
| Drug | dibutyl iodomethaneboronate | 5.60e-05 | 3 | 99 | 2 | CID000098591 | |
| Drug | zinc;dipicolinate | 5.60e-05 | 3 | 99 | 2 | CID004309911 | |
| Drug | 2-oxobut-3-ynoate | 5.60e-05 | 3 | 99 | 2 | CID000171547 | |
| Drug | AFMeq | 5.60e-05 | 3 | 99 | 2 | CID000194069 | |
| Drug | Bz-Cti-otbu | 5.60e-05 | 3 | 99 | 2 | CID006452691 | |
| Drug | n-(2-oxoethyl)benzamide | 5.60e-05 | 3 | 99 | 2 | CID000188995 | |
| Drug | AC1L49DM | 5.60e-05 | 3 | 99 | 2 | CID000152933 | |
| Drug | c140 | 5.60e-05 | 3 | 99 | 2 | CID002783250 | |
| Drug | Benzamidomethaneboronic acid | 5.60e-05 | 3 | 99 | 2 | CID000127677 | |
| Drug | phenyl hippurate | 5.60e-05 | 3 | 99 | 2 | CID000076323 | |
| Drug | FK-386 | 5.60e-05 | 3 | 99 | 2 | CID000135044 | |
| Drug | FK-375 | 5.60e-05 | 3 | 99 | 2 | CID000135042 | |
| Drug | carbostyril-124 | 5.60e-05 | 3 | 99 | 2 | CID000088277 | |
| Drug | N-trifluoroacetyl-4-fluorophenylalanine | 5.60e-05 | 3 | 99 | 2 | CID000328214 | |
| Drug | C18 4 | 5.60e-05 | 3 | 99 | 2 | CID000077248 | |
| Drug | taraxastane | 5.60e-05 | 3 | 99 | 2 | CID006429404 | |
| Drug | Phe-phe-ome | 5.60e-05 | 3 | 99 | 2 | CID000151728 | |
| Drug | phenylethaneboronic acid | 5.60e-05 | 3 | 99 | 2 | CID000065389 | |
| Drug | 3-amino-2-pyridone | 5.60e-05 | 3 | 99 | 2 | CID000322353 | |
| Drug | ASA-BMPA | 5.60e-05 | 3 | 99 | 2 | CID003035649 | |
| Drug | p-nitrophenyl benzoate | 5.60e-05 | 3 | 99 | 2 | CID000070396 | |
| Drug | Z-Phe-OMe | 5.60e-05 | 3 | 99 | 2 | CID003082435 | |
| Drug | 3-methylcoumarin | 5.60e-05 | 3 | 99 | 2 | CID000017130 | |
| Drug | 2-propyl methylphosphonochloridate | 5.60e-05 | 3 | 99 | 2 | CID000102124 | |
| Drug | FK-316 | 5.60e-05 | 3 | 99 | 2 | CID000133688 | |
| Drug | AC1L19T8 | 5.60e-05 | 3 | 99 | 2 | CID000000694 | |
| Drug | Marinostatin D | 5.60e-05 | 3 | 99 | 2 | CID000132206 | |
| Drug | 1FD7 | 5.60e-05 | 3 | 99 | 2 | CID000445579 | |
| Drug | Glt-leu-phe-nh-meq | 5.60e-05 | 3 | 99 | 2 | CID000194914 | |
| Drug | AC1L4Z4F | 5.60e-05 | 3 | 99 | 2 | CID000194913 | |
| Drug | Glt-Phe-NH-FMeq | 5.60e-05 | 3 | 99 | 2 | CID000194912 | |
| Drug | diacetyl trimer | 5.60e-05 | 3 | 99 | 2 | CID000193527 | |
| Drug | FK-448 | 5.60e-05 | 3 | 99 | 2 | CID006917869 | |
| Drug | Ac-Phe-OMe | 5.60e-05 | 3 | 99 | 2 | CID000097805 | |
| Drug | thiobenzyl N-heptafluorobutyrylanthranilate | 5.60e-05 | 3 | 99 | 2 | CID000133906 | |
| Drug | azido-Q | 1.00e-04 | 21 | 99 | 3 | CID000125727 | |
| Drug | Benzoyl-dl-leucine | 1.12e-04 | 4 | 99 | 2 | CID000294887 | |
| Drug | Acafcek | 1.12e-04 | 4 | 99 | 2 | CID000197677 | |
| Drug | B-1,3-od | 1.12e-04 | 4 | 99 | 2 | CID011971053 | |
| Drug | dehydromerodesmosine | 1.12e-04 | 4 | 99 | 2 | CID006443540 | |
| Drug | alpha-amyrin palmitate | 1.12e-04 | 4 | 99 | 2 | CID000185477 | |
| Drug | poly-THIQ | 1.12e-04 | 4 | 99 | 2 | CID006453487 | |
| Drug | N-(4-carboxycyclohexylmethyl)-maleimide | 1.12e-04 | 4 | 99 | 2 | CID011548799 | |
| Drug | G2505_sigma | 1.12e-04 | 4 | 99 | 2 | CID000111098 | |
| Drug | Aprotinin | 1.12e-04 | 4 | 99 | 2 | DB06692 | |
| Drug | p-fluorobenzenesulfonyl chloride | 1.12e-04 | 4 | 99 | 2 | CID000009588 | |
| Drug | BSSDA | 1.12e-04 | 4 | 99 | 2 | CID003081106 | |
| Drug | AC1L2HV6 | 1.12e-04 | 4 | 99 | 2 | CID000047328 | |
| Drug | AC1L4X1Z | 1.12e-04 | 4 | 99 | 2 | CID000193815 | |
| Drug | NSC-676827 | 1.12e-04 | 4 | 99 | 2 | CID000385555 | |
| Drug | 6-amino-1,2-benzopyrone | 1.12e-04 | 4 | 99 | 2 | CID000046152 | |
| Drug | nitrophenylethanol | 1.12e-04 | 4 | 99 | 2 | CID000097851 | |
| Drug | zirconium | 1.25e-04 | 111 | 99 | 5 | CID000023995 | |
| Drug | 7-amino-4-methylcoumarin | 1.27e-04 | 59 | 99 | 4 | CID000092249 | |
| Drug | lead sulfide | 1.42e-04 | 260 | 99 | 7 | CID000014819 | |
| Drug | o-iodosobenzoic acid | 1.45e-04 | 61 | 99 | 4 | CID000067537 | |
| Drug | Ac-Trp-OEt | 1.86e-04 | 5 | 99 | 2 | CID000304749 | |
| Drug | apne | 1.86e-04 | 5 | 99 | 2 | CID000098192 | |
| Drug | Malformin A | 1.86e-04 | 5 | 99 | 2 | CID000004005 | |
| Drug | tilomisole | 1.86e-04 | 5 | 99 | 2 | CID000042747 | |
| Drug | 7-chloro-4-nitrobenzofuran | 1.86e-04 | 5 | 99 | 2 | CID000130782 | |
| Drug | Z-Phe-Leu | 1.86e-04 | 5 | 99 | 2 | CID000333351 | |
| Drug | 5'-FSBAzA | 1.86e-04 | 5 | 99 | 2 | CID000130430 | |
| Drug | AC1L3F57 | 1.86e-04 | 5 | 99 | 2 | CID000139565 | |
| Drug | 3,5-dimethylpyrazole-1-carboxamidine | 1.86e-04 | 5 | 99 | 2 | CID000097525 | |
| Drug | Maap-borov | 1.86e-04 | 5 | 99 | 2 | CID005486914 | |
| Drug | 2-amino-4,6-dichlorotriazine | 1.86e-04 | 5 | 99 | 2 | CID000013615 | |
| Drug | toxiusol | 1.86e-04 | 5 | 99 | 2 | CID000455061 | |
| Disease | level of chymotrypsinogen B2 in blood serum | 1.00e-05 | 2 | 94 | 2 | OBA_2041192 | |
| Disease | chymotrypsinogen B measurement | 3.01e-05 | 3 | 94 | 2 | EFO_0801477 | |
| Disease | Bone Marrow failure syndromes | 6.00e-05 | 4 | 94 | 2 | C2931245 | |
| Disease | Bone marrow failure syndrome 2 | 6.00e-05 | 4 | 94 | 2 | C3810350 | |
| Disease | Bone marrow failure syndrome 1 | 6.00e-05 | 4 | 94 | 2 | C3808553 | |
| Disease | anti-basement membrane glomerulonephritis (biomarker_via_orthology) | 1.19e-04 | 30 | 94 | 3 | DOID:4780 (biomarker_via_orthology) | |
| Disease | Dermatitis, Atopic | 2.07e-04 | 36 | 94 | 3 | C0011615 | |
| Disease | Eczema, Infantile | 2.07e-04 | 36 | 94 | 3 | C0086196 | |
| Disease | hereditary angioedema (is_implicated_in) | 2.09e-04 | 7 | 94 | 2 | DOID:14735 (is_implicated_in) | |
| Disease | eosinophil count | DNAH3 HIVEP1 CDKL3 POR CHD1 CHD7 THOC2 SLAMF1 STAT6 BPTF SLC9A4 TMEM232 TBC1D1 XRN1 | 2.56e-04 | 1488 | 94 | 14 | EFO_0004842 |
| Disease | coiled-coil domain-containing protein 80 measurement | 2.78e-04 | 8 | 94 | 2 | EFO_0020268 | |
| Disease | arteriosclerosis (biomarker_via_orthology) | 2.78e-04 | 8 | 94 | 2 | DOID:2349 (biomarker_via_orthology) | |
| Disease | coffee consumption measurement, tea consumption measurement | 3.77e-04 | 44 | 94 | 3 | EFO_0006781, EFO_0010091 | |
| Disease | Aortic Aneurysm, Abdominal | 4.44e-04 | 10 | 94 | 2 | C0162871 | |
| Disease | trypsin-2 measurement | 5.42e-04 | 11 | 94 | 2 | EFO_0008305 | |
| Disease | cognitive function measurement | VRK2 HIVEP1 DSP CDKL3 CHD7 JMJD1C TTLL7 SHISA9 SLC9A4 KMT2D TMEM232 TBC1D1 ZNF638 | 6.15e-04 | 1434 | 94 | 13 | EFO_0008354 |
| Disease | monokine induced by gamma interferon measurement | 6.18e-04 | 52 | 94 | 3 | EFO_0008236 | |
| Disease | chronic kidney disease (implicated_via_orthology) | 6.49e-04 | 12 | 94 | 2 | DOID:784 (implicated_via_orthology) | |
| Disease | idiopathic pulmonary fibrosis | 8.09e-04 | 57 | 94 | 3 | EFO_0000768 | |
| Disease | abdominal aortic aneurysm (biomarker_via_orthology) | 8.91e-04 | 14 | 94 | 2 | DOID:7693 (biomarker_via_orthology) | |
| Disease | chronic kidney disease (is_implicated_in) | 8.91e-04 | 14 | 94 | 2 | DOID:784 (is_implicated_in) | |
| Disease | triglycerides in small VLDL measurement | 9.86e-04 | 61 | 94 | 3 | EFO_0022145 | |
| Disease | triglycerides in small HDL measurement | 1.03e-03 | 62 | 94 | 3 | EFO_0022158 | |
| Disease | phospholipids in large VLDL measurement | 1.03e-03 | 62 | 94 | 3 | EFO_0022169 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 1.03e-03 | 62 | 94 | 3 | EFO_0022339 | |
| Disease | Drugs used in diabetes use measurement | 1.36e-03 | 255 | 94 | 5 | EFO_0009924 | |
| Disease | cumulative dose response to bevacizumab | 1.66e-03 | 19 | 94 | 2 | EFO_0005944 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.72e-03 | 74 | 94 | 3 | EFO_0022280 | |
| Disease | COVID-19 (is_implicated_in) | 2.03e-03 | 21 | 94 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | hyperglycemia (biomarker_via_orthology) | 2.03e-03 | 21 | 94 | 2 | DOID:4195 (biomarker_via_orthology) | |
| Disease | Alveolitis, Fibrosing | 2.39e-03 | 83 | 94 | 3 | C4721507 | |
| Disease | Pulmonary Fibrosis | 2.56e-03 | 85 | 94 | 3 | C0034069 | |
| Disease | eosinophil percentage of leukocytes | 2.65e-03 | 746 | 94 | 8 | EFO_0007991 | |
| Disease | Hypermetropia, Myopia | 3.17e-03 | 189 | 94 | 4 | HP_0000540, HP_0000545 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HQQAEKKQKNPPYKF | 41 | Q9BT88 | |
| PKSKNLQPKIQEYEF | 121 | O75528 | |
| IGKTYPQQFPKKLKE | 421 | Q5TYW2 | |
| EQKAIKAKYPPVNRK | 16 | Q8IWT0 | |
| KKPNEYSKNLEKTNR | 1011 | Q96QE3 | |
| KTKYNANKTPDKLQQ | 161 | Q6GPI1 | |
| EDAKNPQKNTPKFLY | 181 | Q8N5Z0 | |
| YKTLQAQAPEKSKNK | 321 | P12645 | |
| YKQENPNAPKSKVRK | 171 | Q7Z6V5 | |
| IGKTYPQQFPKKLKE | 421 | Q5CZ79 | |
| VYVKKKAAQGIQKSP | 1201 | Q8N7X0 | |
| IGKTYPQQFPKKLKE | 421 | Q4UJ75 | |
| ALKKAYEIQKNKPRN | 221 | P30556 | |
| PYKVPLNSQIKNLSK | 166 | Q9Y3Q7 | |
| QVQHPKNARKKYPKL | 241 | Q8IVW4 | |
| AQSKPREKYKAPGKN | 126 | A7E2U8 | |
| ENKQPQDSQSYGKKK | 316 | A2A2Z9 | |
| KVLQNNAKYQVVPKK | 46 | Q5JWR5 | |
| FQINGKDNKPKIYLK | 1531 | Q12830 | |
| YLPSIEQQPQQKKKK | 586 | Q9P2D1 | |
| DYEPKNKVKSRKPQN | 181 | O14646 | |
| YQKPTNKHFTQSPKK | 596 | Q76M96 | |
| FNNQKLKVEPGYPKS | 486 | P50281 | |
| NLQKDKPSNPKKENL | 21 | Q6ZP01 | |
| PANKLKNKENVYTPK | 416 | Q14680 | |
| IGKTYPQQFPKKLKE | 421 | Q5SQ80 | |
| LQLESVDPKNYPKKK | 196 | P01584 | |
| ETKKDYEKLQQSPKP | 546 | Q8TDR0 | |
| KPNKDGLKNKANYES | 96 | Q6P0N0 | |
| LKSYENQKPPFDAKN | 266 | P16435 | |
| QQKPDQSPKLLIKYA | 56 | A0A0C4DH24 | |
| RTKRQPKPTYKKKQN | 1641 | Q15652 | |
| PKPTYKKKQNDLQKR | 1646 | Q15652 | |
| NQLCLPPYKSKKDLK | 746 | Q5U5R9 | |
| QQKPDQSPKLLIKYA | 56 | A0A0A0MT36 | |
| QNTKESKNPEQKYKA | 561 | Q6P3R8 | |
| EYQPEQKNKGKFRVP | 51 | Q9Y328 | |
| NQKPPSAEYKVVKAQ | 1496 | O94854 | |
| PPKLTLFNAKYNKIK | 186 | P20774 | |
| DESVQKPKFPKEKQN | 856 | Q8NG31 | |
| KVKDPLIKKNNTYAP | 356 | P14867 | |
| QKKKKQKPAQNYDDN | 386 | Q5F1R6 | |
| NKALTKDPQDYPDKK | 1136 | P09884 | |
| QKQVKENKTQPPVAY | 196 | P63145 | |
| QKQVKENKTQPPVAY | 196 | Q7LDI9 | |
| QKQVKENKTQPPVAY | 196 | P63130 | |
| QKQVKENKTQPPVAY | 196 | P62685 | |
| QKQVKENKTQPPVAY | 196 | P63126 | |
| QKQVKENKTQPPVAY | 196 | P62684 | |
| IGKTYPQQFPKKLKE | 421 | Q5VUR7 | |
| KLQKYINNPDFVPEK | 2856 | Q9C0G6 | |
| FLNDSQASKYPPKKV | 1966 | Q5JSL3 | |
| KNSNGIPKLKYIPLK | 521 | Q8TD57 | |
| EGKKLKPKPNYNSVD | 576 | Q7Z3S7 | |
| QYSKPPHKKLKDRQI | 186 | Q53EP0 | |
| VKNKISLYKKVFPPN | 346 | P49326 | |
| KSKKIVQLKPRNPDY | 441 | P15924 | |
| KTANEKNKVKNQIYP | 576 | Q3MJ40 | |
| NNKKPQKSLTAKYQP | 136 | Q56NI9 | |
| EYQQNKPPGKKKKRA | 1201 | Q2VIQ3 | |
| KRAPPSQKYKSEKQD | 1481 | Q9ULL0 | |
| SLPLYISNPVNQKKK | 1201 | Q5T890 | |
| QNKSYVVACKPPQKK | 126 | Q9H1E1 | |
| KTKYNANKTPDKLQQ | 161 | P17538 | |
| PTPFKNALAAQEKKY | 556 | P10243 | |
| DPKTLAFNPKKKNYE | 366 | Q2NL67 | |
| AFNPKKKNYERLQKA | 371 | Q2NL67 | |
| AKPKPQKVKEIEYQN | 296 | Q4G0U5 | |
| NEPAPGKKKSQIQEY | 241 | P32754 | |
| KNKPSTEEKLKSYQP | 416 | Q9BYT3 | |
| KKYKQNTQGLKSPEN | 61 | Q8N6K7 | |
| GFSYVKIPNKPTQQK | 981 | Q8IZX4 | |
| YKSSNKQPKPTKQPR | 326 | O94933 | |
| NKYNLKPQTSEKQAK | 611 | Q6AI14 | |
| YAQVQKPGPLQKKLD | 281 | Q13291 | |
| QQPPGKELNKYASLK | 266 | B4DS77 | |
| PSKFPNKNLKKNYCR | 221 | P00747 | |
| QKQVKENKTQPPVAY | 196 | P63128 | |
| PTPQKLAYEKKQNDQ | 176 | Q86WS4 | |
| ENLQKYKAAKNPSPT | 826 | Q9ULV3 | |
| NYSSDLGKQPKKVPK | 306 | Q9UNS1 | |
| PKPYKCQQPKNKKAF | 161 | Q9H0M5 | |
| PTAVKNLYQSEKPQK | 516 | Q9H900 | |
| PYPNEKDKEKNKSKS | 1521 | Q8NI27 | |
| PSIKKDQTKYPNKKL | 541 | C9JQI7 | |
| QQEEYKKKVAALPKQ | 311 | Q9GZZ9 | |
| QLKNLYPKKPKDEAF | 611 | P42226 | |
| KQQPKDVPYKELLKQ | 826 | Q86TI0 | |
| QQFVPPTQSKKEKKD | 66 | Q8IY57 | |
| KKKKNREFYPSNLTP | 406 | O43280 | |
| RDEYGLPSQPKQNKK | 1391 | Q8IZH2 | |
| LVLDPTPNKKKQVKY | 731 | Q9Y4R7 | |
| KQPQGSLKIATKPKY | 281 | Q86YA3 | |
| INYKQDKKNQKPSEA | 356 | Q9BXG8 | |
| NAPYFKPKVKVSFKN | 81 | Q8TB96 | |
| PESKKNQKKQYQLPS | 631 | Q96LC7 | |
| KKYKPLNTTPNATKE | 261 | Q96QC0 | |
| KQNYIPVKNGKQFTK | 96 | P15822 | |
| PPDKSSGSKKQKQYQ | 51 | Q9Y4P3 | |
| DEKPNYQALKKILNP | 301 | Q86Y07 | |
| KKNLKPNIDLPSCYK | 191 | Q96RE9 | |
| EKPAENTLFKAYPNK | 1351 | Q14966 | |
| KKKDPNEPQKPVSAY | 216 | O94842 | |
| KALGPKNANKYLLKP | 951 | Q562E7 | |
| QNKKREKQVTYNLKP | 571 | Q6ZT98 | |
| KYPQNKDKLGKQPER | 126 | Q8IZ20 | |
| KVPAADKAPYLQKAK | 2051 | O14686 | |
| RPADQYKDPQSKKKG | 1186 | Q9UM54 | |
| IFLKYPQEKNNGPKV | 816 | Q9NZM1 | |
| KEKGKTPKYNPKDSQ | 5801 | P20929 | |
| KKSPSAKLNIPYENF | 686 | P29120 | |
| YPDSVKKENKNPVNN | 466 | Q9NQS3 |